Performance & Impact

Hangaia te ā mua

Create the future

UniServices is one of Australasia’s largest research commercialisation and venture creation companies, connecting industry with innovation from New Zealand’s largest university, the University of Auckland. We’ve invested in over 75 companies and licensed more than 540 patent families. 
iStock 1341631834

Hangaia te ā mua

Create the future

UniServices is one of Australasia’s largest research commercialisation and venture creation companies, connecting industry with innovation from New Zealand’s largest university, the University of Auckland. We’ve invested in over 75 companies and licensed more than 540 patent families. 

UniServices by the Numbers

36

new companies launched between 2020-2025

35

patents licensed in 2024

$41m

– Fair value of the University of Auckland Inventors’ Fund at the end of 2023

Latest Highlights

Research Impact

Top in Australasia for active spin-outs

Ranked No. 1 in Australasia for active spin-outs, strengthening our role as a leading venture-creator.  UniServices (and its parent University of Auckland) ranked #1 among 70+ Australian & New Zealand institutions in the number of active spin-out companies (47 from 2021-2023). 

Major biopharma commercial deal with China

Landmark commercialisation deal with China, bringing a New Zealand-led cancer therapeutic to the global stage. In November 2024 UniServices announced the signing of a large patent acquisition deal for a novel oncology treatment (LX-132) with a Chinese biotech partner, described as “one of the largest biopharmaceutical commercialisation deals between New Zealand and China".

 

Global vaccine research partnership

In July 2024, UniServices and Kyushu University in Japan signed a Memorandum of Understanding to share vaccine research and data as part of the Global Vaccine Data Network, with Ki­ng Luxon calling it “an excellent example of New Zealand demonstrating leadership of a global initiative in research and science.” 

Enterprise value of NZ university spin-outs hits NZ$2.2 billion

University spin-outs reach a combined enterprise value of over NZ$2.2 billion and creating hundreds of skilled jobs. UniServices is proud to play a key role in the University of Auckland innovation ecosystem helping to deliver these outcomes. (August 2025)

Investment Impact

Better optical communications

Quantifi Photonics, a University of Auckland spin-out, manufactures equipment for photonics testing and measurement in areas such as optical communications. It raised US$15 million in Series C funding to accelerate the development of test solutions for datacom and telecom equipment manufacturers. It also acquired SmarTest Electronics, giving it research and manufacturing facilities in Thailand.

Diagnosing gut disorders

Alimetry is an Auckland based MedTech company that develops advanced wearable medical solutions that improve gastrointestinal care. Founded in 2019, based on a decade of groundbreaking science and engineering out of Waipapa Taumata Rau, the University of Auckland, Alimetry is striving to develop solutions that are more effective, easier on patients, and more efficient for healthcare providers. In 2022, Alimetry received FDA approval in the US for its flagship Gastric Alimetry device, a non-invasive tool to diagnose disorders of the upper gut, and has raised $16.3 million in Series A funding.